Heidelberg, Germany

Klaus Schewiola

This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Deutsches Krebsforschungszentrum. Active years: 2015-2019.

USPTO Granted Patents = 3 

% Patents Active = 100.0


 

Average Co-Inventor Count = 2.3

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2015-2019

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Klaus Schewiola: Innovator in Radiotherapy Technology

Introduction

Klaus Schewiola is a notable inventor based in Heidelberg, Germany. He has made significant contributions to the field of radiotherapy, particularly through his innovative designs that enhance the precision and efficiency of treatment.

Latest Patents

Klaus Schewiola holds 3 patents, with his latest invention being a contour collimator for radiotherapy. This invention comprises a plurality of plate-shaped diaphragm elements arranged in a guiding block, which are movably positioned to form a contour diaphragm for a radiation beam emitted by a radiation source. Each diaphragm element is associated with its own drive, specifically a linear motor, allowing for precise and stable adjustability without backlash. This design aims to create a compact contour collimator while improving the overall functionality of radiotherapy equipment.

Career Highlights

Klaus Schewiola is affiliated with the Deutsches Krebsforschungszentrum, where he has been instrumental in advancing radiotherapy technologies. His work focuses on enhancing the effectiveness of cancer treatment through innovative engineering solutions.

Collaborations

Klaus has collaborated with notable colleagues such as Steffen Seeber and Gernot Echner, contributing to a dynamic research environment that fosters innovation in cancer research and treatment technologies.

Conclusion

Klaus Schewiola's contributions to radiotherapy through his innovative patents and collaborative efforts highlight his commitment to improving cancer treatment. His work continues to influence the field positively, paving the way for advancements in medical technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…